Compare ABM & TXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ABM | TXG |
|---|---|---|
| Founded | 1909 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Diversified Commercial Services | Biotechnology: Laboratory Analytical Instruments |
| Sector | Finance | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.6B | 2.1B |
| IPO Year | N/A | 2019 |
| Metric | ABM | TXG |
|---|---|---|
| Price | $42.62 | $16.66 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 4 | 13 |
| Target Price | ★ $54.25 | $15.42 |
| AVG Volume (30 Days) | 874.2K | ★ 1.8M |
| Earning Date | 12-17-2025 | 02-11-2026 |
| Dividend Yield | ★ 2.74% | N/A |
| EPS Growth | ★ 102.34 | N/A |
| EPS | ★ 2.59 | N/A |
| Revenue | ★ $8,745,900,000.00 | $641,814,000.00 |
| Revenue This Year | $5.51 | $4.50 |
| Revenue Next Year | $3.68 | N/A |
| P/E Ratio | $16.33 | ★ N/A |
| Revenue Growth | ★ 4.62 | 1.92 |
| 52 Week Low | $40.00 | $6.78 |
| 52 Week High | $54.90 | $20.34 |
| Indicator | ABM | TXG |
|---|---|---|
| Relative Strength Index (RSI) | 45.23 | 51.47 |
| Support Level | $41.42 | $15.91 |
| Resistance Level | $43.19 | $16.86 |
| Average True Range (ATR) | 1.48 | 0.69 |
| MACD | -0.26 | -0.07 |
| Stochastic Oscillator | 13.51 | 71.11 |
ABM Industries Inc is a provider of integrated facility solutions. It offers its solutions through five segments: Business and Industry, Manufacturing and Distribution, Education, Aviation and Technical solutions. The company derives the majority of its revenue from the business and industry segment, which encompasses janitorial, facilities engineering, and parking services for commercial real estate properties and sports and entertainment venues, hospitals, as well as vehicle maintenance and other services to rental car providers. The company mainly operates in the United States of America.
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The company's integrated solutions include instruments, consumables, and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. Its product offerings include a Chromium platform comprising microfluidic chips and related consumables, Chromium X series, Visium and Xenium platforms, and others, which are predominantly used for the study of biological components. Geographically, the company derives maximum revenue from the United States and the rest from Americas (excluding the United States), Europe, Middle East and Africa, China, and Asia-Pacific (excluding China).